NASDAQ: SBFMSunshine Biopharma Inc Stock Ownership - Who owns Sunshine Biopharma?
Insider buying vs selling
Have Sunshine Biopharma Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when SBFM insiders and whales buy or sell their stock.
SBFM Shareholders
What type of owners hold Sunshine Biopharma Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Malek Chamoun | 75.42% | 3,700,000 | $5.29M | Insider |
| Camille Sebaaly | 3.56% | 174,465 | $249.48k | Insider |
| Steve N. Slilaty | 2.65% | 130,000 | $185.90k | Insider |
| Citadel Advisors LLC | 1.59% | 78,087 | $111.66k | Institution |
| Renaissance Technologies LLC | 1.14% | 55,700 | $79.65k | Institution |
| Drw Securities LLC | 0.92% | 44,977 | $64.32k | Institution |
| Two Sigma Investments LP | 0.44% | 21,399 | $30.60k | Institution |
| Two Sigma Securities LLC | 0.35% | 17,176 | $24.56k | Institution |
| Sbi Securities Co Ltd | 0.10% | 4,850 | $6.94k | Institution |
| Morgan Stanley | 0.08% | 3,834 | $5.48k | Institution |
SBFM vs Pharmaceutical Stocks
Sunshine Biopharma Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.